Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2019

Open Access 01-12-2019 | ANCA-Associated Vasculitis | Research article

Invasive mycoses in patients with connective tissue disease from Southern China: clinical features and associated factors

Authors: Minxi Lao, Zhongping Zhan, Fan Su, Hao Li, Zheng Yang, Haihong Chen, Liuqin Liang, Dongying Chen

Published in: Arthritis Research & Therapy | Issue 1/2019

Login to get access

Abstract

Background

A retrospective study was performed to investigate the clinical features and associated factors of invasive mycoses (IM) in patients with connective tissue disease (CTD) from Southern China.

Methods

Demographic and clinical data were recorded. Associated factors were analyzed by logistic regression analysis.

Results

A total of 6911 patients with CTD were included. IM was diagnosed in 32 patients (incidence, 0.5%). IM was predominant in patients with ANCA-associated vasculitis (AAV) (incidence, 1.5%, 7/480). Lung was commonly involved (30/32, 93.8%). Aspergillus spp. (81.3%) were the leading strain. The positive rate of fungi detection in sputum culture was 69.0%. Serum galactomannan (GM) test was positive in bronchoalveolar lavage fluid (BALF) from seven (7/10, 70.0%) patients. Ten patients died (31.3%), including three with AAV (42.9%) and seven with SLE (36.8%). Penicillium marneffei was the most fatal (mortality, 100%). Non-survivors had higher prevalence of leukopenia (30.0% vs 4.5%, P = 0.04), lymphopenia (100.0% vs 59.1%, P = 0.02), elevated serum creatinine (70.0% vs 27.3%, P = 0.02), and co-infection (70.0% vs 18.2%, P = 0.004) than survivors. Multivariate logistic regression analysis showed that lymphopenia [odds ratio (OR) = 3.28, 95% confidence interval (CI) 1.29–8.38, P = 0.01] and median-to-high dose of glucocorticoid (GC) [OR = 3.40, 95% CI 1.04–11.13, P = 0.04] were associated with IM in patients with CTD.

Conclusions

IM tended to develop in patients with AAV, resulting in high mortality. Sputum culture and GM test in BALF were effective methods to distinguish IM. Vigilance against lymphopenia, impaired kidney function, and co-infection improved the prognosis of IM.
Appendix
Available only for authorised users
Literature
1.
go back to reference Goldblatt F, Chambers S, Rahman A, Isenberg DA. Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus. 2009;18:682–9.CrossRef Goldblatt F, Chambers S, Rahman A, Isenberg DA. Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus. 2009;18:682–9.CrossRef
2.
go back to reference Wu XY, Yang M, Xie YS, Xiao WG, Lin J, Zhou B, Guan X, Luo CN, Che N, Liu XZ, et al. Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort. Clin Rheumatol. 2019;38:107–115. Wu XY, Yang M, Xie YS, Xiao WG, Lin J, Zhou B, Guan X, Luo CN, Che N, Liu XZ, et al. Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort. Clin Rheumatol. 2019;38:107–115.
3.
go back to reference Yang L, Xie H, Liu Z, Chen Y, Wang J, Zhang H, Ge Y, Hu W. Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study. BMC Nephrol. 2018;19:138.CrossRef Yang L, Xie H, Liu Z, Chen Y, Wang J, Zhang H, Ge Y, Hu W. Risk factors for infectious complications of ANCA-associated vasculitis: a cohort study. BMC Nephrol. 2018;19:138.CrossRef
4.
go back to reference Wangkaew S, Prasertwitayakij N, Phrommintikul A, Puntana S, Euathrongchit J. Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study. Rheumatol Int. 2017;37:2087–94.CrossRef Wangkaew S, Prasertwitayakij N, Phrommintikul A, Puntana S, Euathrongchit J. Causes of death, survival and risk factors of mortality in Thai patients with early systemic sclerosis: inception cohort study. Rheumatol Int. 2017;37:2087–94.CrossRef
5.
go back to reference Murray SG, Schmajuk G, Trupin L, Lawson E, Cascino M, Barton J, Margaretten M, Katz PP, Yelin EH, Yazdany J. Infection is the leading cause of hospital mortality in patients with dermatomyositis/polymyositis: data from a population based study. Arthritis Care Res (Hoboken). 2015;67:673–80.CrossRef Murray SG, Schmajuk G, Trupin L, Lawson E, Cascino M, Barton J, Margaretten M, Katz PP, Yelin EH, Yazdany J. Infection is the leading cause of hospital mortality in patients with dermatomyositis/polymyositis: data from a population based study. Arthritis Care Res (Hoboken). 2015;67:673–80.CrossRef
6.
go back to reference Slavin MA, Chakrabarti A. Opportunistic fungal infections in the Asia-Pacific region. Med Mycol. 2012;50:18–25.CrossRef Slavin MA, Chakrabarti A. Opportunistic fungal infections in the Asia-Pacific region. Med Mycol. 2012;50:18–25.CrossRef
7.
go back to reference Sahin SZ, Akalin H, Ersoy A, Yildiz A, Ocakoglu G, Cetinoglu ED, Dizdar OS, Kazak E, Ener B. Invasive Fungal Infections in Renal Transplant Recipients: Epidemiology and risk factors. Mycopathologia. 2015;180:43–50.CrossRef Sahin SZ, Akalin H, Ersoy A, Yildiz A, Ocakoglu G, Cetinoglu ED, Dizdar OS, Kazak E, Ener B. Invasive Fungal Infections in Renal Transplant Recipients: Epidemiology and risk factors. Mycopathologia. 2015;180:43–50.CrossRef
8.
go back to reference Wang LR, Barber CE, Johnsona S, Barnabe C. Invasive fungal disease in systemic lupus erythematosus: a systematic review of disease characteristics, risk factors, and prognosis. Semin Arthritis Rheum. 2014;44:325–30.CrossRef Wang LR, Barber CE, Johnsona S, Barnabe C. Invasive fungal disease in systemic lupus erythematosus: a systematic review of disease characteristics, risk factors, and prognosis. Semin Arthritis Rheum. 2014;44:325–30.CrossRef
9.
go back to reference Martínez-Martínez MU, Herrera-Van Oosdam D, Roman-Acosta S, Magaña-Aquino M, Baranda-Cándido L, Abud-Mendoza C. Invasive fungal infections in patients with systemic lupus erythomatosus. J Rheumatol. 2012;39:1814–8.CrossRef Martínez-Martínez MU, Herrera-Van Oosdam D, Roman-Acosta S, Magaña-Aquino M, Baranda-Cándido L, Abud-Mendoza C. Invasive fungal infections in patients with systemic lupus erythomatosus. J Rheumatol. 2012;39:1814–8.CrossRef
10.
go back to reference Santamaría-Alza Y, Sánchez-Bautista J, Fajardo-Rivero JF, Figueroa CL. Invasive fungal infections in Colombian patients with systemic lupus erythomatosus. Lupus. 2018;27:1116–22.CrossRef Santamaría-Alza Y, Sánchez-Bautista J, Fajardo-Rivero JF, Figueroa CL. Invasive fungal infections in Colombian patients with systemic lupus erythomatosus. Lupus. 2018;27:1116–22.CrossRef
11.
go back to reference Su T, Li HC, Chen M, Gao L, Zhou FD, Wang RG, Zhang H, Li XM, Zhao MH. Invasive pulmonary aspergillosis in patients with antineutrophil cytoplasmic antibody associated vasculitis. J Clin Rheumatol. 2009;15:380–2.CrossRef Su T, Li HC, Chen M, Gao L, Zhou FD, Wang RG, Zhang H, Li XM, Zhao MH. Invasive pulmonary aspergillosis in patients with antineutrophil cytoplasmic antibody associated vasculitis. J Clin Rheumatol. 2009;15:380–2.CrossRef
12.
go back to reference Hidron A, Franco-Paredes C, Drenkard C. A rare opportunistic infection in a woman with systemic lupus erythematosus and multiple skin lesions. Lupus. 2009;18(12):1100–3.CrossRef Hidron A, Franco-Paredes C, Drenkard C. A rare opportunistic infection in a woman with systemic lupus erythematosus and multiple skin lesions. Lupus. 2009;18(12):1100–3.CrossRef
13.
go back to reference Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythomatosus. Arthritis Rheum. 1997;40:1725.CrossRef Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythomatosus. Arthritis Rheum. 1997;40:1725.CrossRef
14.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–24.CrossRef Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–24.CrossRef
15.
go back to reference Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–92.CrossRef Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–92.CrossRef
16.
go back to reference Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1–11.CrossRef Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65:1–11.CrossRef
17.
go back to reference Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344–7.CrossRef Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344–7.CrossRef
18.
go back to reference American Rheumatism Association. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee. Arthritis Rheum. 1980;23:581–90.CrossRef American Rheumatism Association. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American rheumatism association diagnostic and therapeutic criteria committee. Arthritis Rheum. 1980;23:581–90.CrossRef
19.
go back to reference De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses. Clin Infect Dis. 2008;46:1813–21.CrossRef De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses. Clin Infect Dis. 2008;46:1813–21.CrossRef
20.
go back to reference Chen D, Xie J, Chen H, Yang Y, Zhan Z, Liang L, Yang X. Infection in Southern Chinese Patients with Systemic Lupus Erythematosus: Spectrum, drug resistance, outcomes, and risk factors. J Rheumatol. 2016;43:1650–66.CrossRef Chen D, Xie J, Chen H, Yang Y, Zhan Z, Liang L, Yang X. Infection in Southern Chinese Patients with Systemic Lupus Erythematosus: Spectrum, drug resistance, outcomes, and risk factors. J Rheumatol. 2016;43:1650–66.CrossRef
21.
go back to reference Group of Pulmonary Vascular and Interstitial Diseases Associated with Rheumatic Diseases, Chinese Association of Rheumatology and Immunology Physicians, Chinese Rheumatic Disease Data Center. 2018 Chinese expert-based consensus statement regarding the diagnosis and treatment of interstitial lung disease associated with connective tissue diseases. Zhonghua Nei Ke Za Zhi. 2018;57:558–65. Group of Pulmonary Vascular and Interstitial Diseases Associated with Rheumatic Diseases, Chinese Association of Rheumatology and Immunology Physicians, Chinese Rheumatic Disease Data Center. 2018 Chinese expert-based consensus statement regarding the diagnosis and treatment of interstitial lung disease associated with connective tissue diseases. Zhonghua Nei Ke Za Zhi. 2018;57:558–65.
22.
go back to reference Lao M, Wang X, Ding M, Yang Z, Chen H, Liang L, Zhan Z, Chen D. Invasive fungal disease in patients with systemic lupus erythematosus from Southern China: a retrospective study. Lupus. 2019;28(1):77–85.CrossRef Lao M, Wang X, Ding M, Yang Z, Chen H, Liang L, Zhan Z, Chen D. Invasive fungal disease in patients with systemic lupus erythematosus from Southern China: a retrospective study. Lupus. 2019;28(1):77–85.CrossRef
23.
go back to reference Charles P, Néel A, Tieulié N, Hot A, Pugnet G, Decaux O, Marie I, Khellaf M, Kahn JE, Karras A, et al. Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients. Rheumatology. 2014;53:532–9.CrossRef Charles P, Néel A, Tieulié N, Hot A, Pugnet G, Decaux O, Marie I, Khellaf M, Kahn JE, Karras A, et al. Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients. Rheumatology. 2014;53:532–9.CrossRef
24.
go back to reference Yoo J, Jung SM, Song JJ, Park YB, Lee SW. Birmingham vasculitis activity and chest manifestation at diagnosis can predict hospitalised infection in ANCA-associated vasculitis. Clin Rheumatol. 2018;37:2133–41.CrossRef Yoo J, Jung SM, Song JJ, Park YB, Lee SW. Birmingham vasculitis activity and chest manifestation at diagnosis can predict hospitalised infection in ANCA-associated vasculitis. Clin Rheumatol. 2018;37:2133–41.CrossRef
25.
go back to reference Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, Anaissie EJ, Brumble LM, Herwaldt L, Ito J, et al. Invasive fungal infections among organ transplant recipients: results of the transplant-associated infection surveillance network (TRANSNET). Clin Infect Dis. 2010;50:1101–11.CrossRef Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, Anaissie EJ, Brumble LM, Herwaldt L, Ito J, et al. Invasive fungal infections among organ transplant recipients: results of the transplant-associated infection surveillance network (TRANSNET). Clin Infect Dis. 2010;50:1101–11.CrossRef
26.
go back to reference Guo YL, Chen YQ, Wang K, Qin SM, Wu C, Kong JL. Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest. 2010;138:817–24.CrossRef Guo YL, Chen YQ, Wang K, Qin SM, Wu C, Kong JL. Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest. 2010;138:817–24.CrossRef
27.
go back to reference Tabarsi P, Soraghi A, Marjani M, Zandian P, Baghaei P, Najafizadeh K, Droudinia A, Sarrafzadeh SA, Javanmard P, Mansouri D. Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid organ transplant recipients. Exp Clin Transpl. 2012;10:278–81.CrossRef Tabarsi P, Soraghi A, Marjani M, Zandian P, Baghaei P, Najafizadeh K, Droudinia A, Sarrafzadeh SA, Javanmard P, Mansouri D. Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid organ transplant recipients. Exp Clin Transpl. 2012;10:278–81.CrossRef
28.
go back to reference Magira EE, Jiang Y, Economides M, Tarrand J, Kontoyiannis DP. Mixed mold pulmonary infections in haematological cancer patients in a tertiary care cancer centre. Mycoses. 2018;61:861–7. Magira EE, Jiang Y, Economides M, Tarrand J, Kontoyiannis DP. Mixed mold pulmonary infections in haematological cancer patients in a tertiary care cancer centre. Mycoses. 2018;61:861–7.
29.
go back to reference Singh JA, Hossain A, Kotb A, Wells G. Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis. BMC Med. 2016;14:137.CrossRef Singh JA, Hossain A, Kotb A, Wells G. Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis. BMC Med. 2016;14:137.CrossRef
30.
go back to reference Goupil R, Brachemi S, Nadeau-Fredette AC, Déziel C, Troyanov Y, Lavergne V, Troyanov S. Lymphopenia and treatment-related infectious complications in ANCA-associated Vasculitis. Clin J Am Soc Nephrol. 2013;8:416–23.CrossRef Goupil R, Brachemi S, Nadeau-Fredette AC, Déziel C, Troyanov Y, Lavergne V, Troyanov S. Lymphopenia and treatment-related infectious complications in ANCA-associated Vasculitis. Clin J Am Soc Nephrol. 2013;8:416–23.CrossRef
Metadata
Title
Invasive mycoses in patients with connective tissue disease from Southern China: clinical features and associated factors
Authors
Minxi Lao
Zhongping Zhan
Fan Su
Hao Li
Zheng Yang
Haihong Chen
Liuqin Liang
Dongying Chen
Publication date
01-12-2019

Other articles of this Issue 1/2019

Arthritis Research & Therapy 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.